Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,312,370
+$12,395,244 QoQ
Shares Held
369,878
+151.6% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#268
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SHELTON CAPITAL MANAGEMENT holds $166,003,072 across 9 Drug Manufacturers - General names. BMY ranks #5 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
282,635 | $36,318,597 | |
| 2 | JNJ |
Johnson & Johnson
|
113,733 | $28,884,770 | |
| 3 | LLY |
ELI LILLY & Co
|
21,997 | $26,383,863 | |
| 4 | AMGN |
Amgen Inc
|
63,607 | $23,033,366 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
369,878 | $21,312,370 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
138,734 | $17,527,653 | |
| 7 | ABBV |
AbbVie Inc.
|
42,182 | $10,614,678 | |
| 8 | PFE |
Pfizer Inc
|
61,912 | $1,490,840 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,312,370 | 369,878 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,917,126 | 147,026 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,546,066 | 232,593 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,178,048 | 380,888 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,033,007 | 367,963 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $27,998,740 | 459,071 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,170,807 | 215,184 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,695,694 | 110,083 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,948,465 | 119,154 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,532,274 | 120,455 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,467,779 | 126,053 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,824,140 | 134,806 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,761,405 | 137,004 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $11,768,976 | 169,802 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,575,810 | 35,800 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,179,473 | 115,058 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,424,186 | 96,418 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,450,593 | 102,021 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,726,908 | 59,774 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,797,121 | 97,974 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,848,431 | 57,594 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,615,749 | 25,594 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,630,582 | 26,287 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $11,034,094 | 183,017 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,547,910 | 26,325 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,441,269 | 25,857 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||